Press release
US Specialty Pharmaceutical Market Key Trends, Size, Growth, Shares And Forecast Research Report 2015
Researchmoz added Most up-to-date research on "The US Specialty Pharmaceutical Market Report: 2015 Edition" to its huge collection of research reports.Specialty pharmaceuticals are typically high-cost, scientifically engineered drugs used to treat complex, chronic conditions that require special storage, warranting special handling, and temperature-control monitoring. These products are often manufactured for small populations of people suffering from somewhat rare, life-threatening and debilitating diseases. The specialty pharmaceuticals are mostly injectable or infused medicines but may also encompass oral medications.
Currently, specialty drugs are one of the fastest growing segments of the overall pharmaceutical market, as sales growth is being driven by improved efficacy compared with currently marketed therapies, while expanded indications for already marketed drugs and off label prescribing can drive sales of these drugs by increasing potential patient populations. The key factors driving growth of the US specialty pharmaceutical industry include accelerating US aging population, ameliorating economic condition, increased life expectancy, and increasing healthcare expenditure. Apart from these growth drivers, many challenges lie ahead for the specialty pharmaceutical market in the US, including the changes in reimbursement process due to healthcare reforms, regulatory pressures, narrowing specialty pharmacy networks and lack of access to specialty pharmacy products.
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=258153
Some of the noteworthy trends and developments of this industry include novel specialty product launches, growing Hepatitis-C segment, increased spending on specialty drugs and ongoing merger & acquisition activities. The percentage of specialty pharmaceuticals sales of the overall US pharmaceuticals sales continues to rise.
The report, “The US Specialty Pharmaceuticals Market: 2015 Edition” analyzes the growth and development of specialty pharmaceutical in the US. Apart from providing a competitive landscape of the market, the report also profiles the major companies including Amgen, Pfizer, Johnson & Johnson and Merck and Co., along with a discussion of their key financials and business strategies.
By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the industry. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.
Table of Content
1. Overview1.1 Specialty Pharmaceuticals Vs Traditional Drugs
1.2 Applications of Specialty Pharmaceuticals
1.3 Specialty Pharmacy Services
1.3.1 Packaging and Delivery Services
1.3.2 Reimbursement Services
1.3.3 Inbound and Outbound Clinical Support
1.3.4 Compliance and Persistence Program
1.4 Specialty Product Distribution
1.4.1 Distribution Services
1.5 Specialty Pharma Manufacturer Services
1.6 Value Proposition of Specialty Pharmacy
2. The US Specialty Pharmaceutical Market
- Market Value
- Traditional Vs Specialty
- Sales by Dispensing Channels
2.1 The US Specialty Market by Therapeutic Area
2.2 Specialty Pharmacy in the US
3. Market Dynamics
3.1 Key Trends and Developments
3.1.1 PBM Mergers and Acquisitions
3.1.2 Increased Specialty Drug Spend
3.1.3 Increasing Number of Specialty Pharmacy Providers
3.1.4 Oncology: No Longer Fastest Growing Specialty Sector
3.1.5 New Product Launches
3.2 Growth Drivers
3.2.1 Accelerating US Aging Population
3.2.2 Increasing Life Expectancy Rate in the US
3.2.3 Rising Incidences of Complex Chronic and Infectious Diseases
3.2.4 Rising Pharmaceutical Sales
3.2.5 Escalating Healthcare Expenditure in the US
3.2.6 Ameliorating Economic Conditions
3.2.7 Rising Medicare Enrollments
3.3 Challenges
3.3.1 Intensifying Pricing Pressure
3.3.2 Narrowing Specialty Pharmacy Networks
3.3.3 Lack of Access to Specialty Pharmacy Products
3.3.4 Regulatory Issues
3.4 Specialty Pharmaceuticals: Pipeline Update
4. Competitive Landscape
4.1 Competition by Drugs
4.2 Competition by Mail Pharmacy
4.3 Competition by Specialty Distributor
5. Company Profiles
5.1 Johnson & Johnson
5.1.1 Business Overview
5.1.2 Financial Overview
5.1.3 Business Strategies
- New Product Launch
- Pursue Strategic Acquisitions
5.2 Amgen Inc.
5.2.1 Business Overview
5.2.2 Financial Overview
5.2.3 Business Strategies
- Global Expansion
- Growth through Acquisitions
5.3 Merck & Co.
5.3.1 Business Overview
5.3.2 Financial Overview
5.3.3 Business Strategies
- Augmented Research and Development
- Research Collaborations and License Agreements
5.4 Pfizer Inc.
5.4.1 Business Overview
5.4.2 Financial Overview
5.4.3 Business Strategies
- Focus on Unmet Needs of Patients
- Pioneering New Collaborations
6. Market Outlook
6.1 Market Forecast
6.2 Forecast Methodology
6.2.1 Dependent and Independent Variables
6.2.2 Correlation Analysis
6.2.3 Regression Analysis
Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=258153
About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
Mr. Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Email: sales@researchmoz.us
Website @ http://www.researchmoz.us/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-621-2074
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release US Specialty Pharmaceutical Market Key Trends, Size, Growth, Shares And Forecast Research Report 2015 here
News-ID: 576923 • Views: …
More Releases from Specialty Pharmaceutical Market

Global Specialty Pharmaceutical Market to 2025| Purdue Pharma, Tevu Pharma, SEP, …
Researchmoz added Most up-to-date research on “Global Specialty Pharmaceutical Market Insights, Forecast to 2025” to its huge collection of research reports.
This report studies the global market size of Specialty Pharmaceutical in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Specialty Pharmaceutical in these regions.
To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=1932370
This research report categorizes the…

Global Specialty Pharmaceutical Market Research Report 2018 : Pfizer, Roche, Amg …
Researchmoz added Most up-to-date research on "Global Specialty Pharmaceutical Market Research Report 2018" to its huge collection of research reports.
In this report, the global Specialty Pharmaceutical market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.
Geographically, this report is segmented into several key Regions, with production, consumption, revenue…

New Market Research Report Announced on Specialty Pharmaceutical Market ; US Ind …
Albany, NY, 2nd February : Recent research and the current scenario as well as future market potential of "The US Specialty Pharmaceutical Market: Industry Analysis & Outlook (2017-2021)" globally.
The US pharmaceutical market is segregated into two types of drugs majorly i.e. traditional drugs and specialty drugs. Specialty drugs in recent times have gained a strong foothold in the US and are likely to experience robust growth in the coming years,…
More Releases for Pharma
Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031.
The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…